WallStSmart

Diversified Healthcare Trust (DHC)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 751% more annual revenue ($12.76B vs $1.50B). WELL leads profitability with a 12.1% profit margin vs -17.7%. DHC appears more attractively valued with a PEG of 1.89. WELL earns a higher WallStSmart Score of 57/100 (C).

DHC

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.3Quality: 5.5
Piotroski: 5/9Altman Z: -0.24

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHCUndervalued (+89.2%)

Margin of Safety

+89.2%

Fair Value

$57.97

Current Price

$7.50

$50.47 discount

UndervaluedFair: $57.97Overvalued
WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$235.62

$109.65 premium

UndervaluedFair: $125.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

DHC4 concerns · Avg: 3.0/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Market CapQuality
$1.82B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.533/10

Elevated debt levels

Return on EquityProfitability
-19.8%2/10

ROE of -19.8% — below average capital efficiency

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Market Cap, Debt/Equity. Debt-to-equity of 1.53 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

DHC profiles as a turnaround stock while WELL is a growth play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.28 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 37/100) and 39.1% revenue growth. DHC offers better value entry with a 89.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?